Author:
Thami Prisca K.,Choga Wonderful,Mulisa Delesa D.,Dandara Collet,Shevchenko Andrey K.,Leteane Melvin M.,Novitsky Vlad,O’Brien Stephen J.,Essex Myron,Gaseitsiwe Simani,Chimusa Emile R.
Abstract
ABSTRACTDespite the high burden of HIV-1 in Botswana, the population of Botswana is significantly underrepresentation in host genetics studies of HIV-1. Furthermore, the bulk of previous genomics studies evaluated common human genetic variations, however, there is increasing evidence of the influence of rare variants in the outcome of diseases which may be uncovered by comprehensive complete and deep genome sequencing. This research aimed to evaluate the role of rare-variants in susceptibility to HIV-1 and progression through whole genome sequencing. Whole genome sequences (WGS) of 265 HIV-1 positive and 125 were HIV-1 negative unrelated individuals from Botswana were mapped to the human reference genome GRCh38. Population joint variant calling was performed using Genome Analysis Tool Kit (GATK) and BCFTools. Cumulative effects of rare variant sets on susceptibility to HIV-1 and progression (CD4+ T-cell decline) were determined with optimized Sequence Kernel Association Test (SKAT-O). In silico functional analysis of the prioritized variants was performed through gene-set enrichment using databases in GeneMANIA and Enrichr. Novel rare-variants within the ANKRD39 (8.48 × 10−8), LOC105378523 (7.45 × 10−7) and GTF3C3 (1.36 × 10−6) genes were significantly associated with HIV-1 progression. Functional analysis revealed that these genes are involved in viral translation and transcription. These findings highlight the significance of whole genome sequencing in pinpointing rare-variants of clinical relevance. The research contributes towards a deeper understanding of the host genetics HIV-1 and offers promise of population specific interventions against HIV-1.
Publisher
Cold Spring Harbor Laboratory
Reference68 articles.
1. UNAIDS (2019) UNAIDS data 2019. UNAIDS data 2019 https://www.unaids.org/en/regionscountries/countries/botswana (accessed Mar 6, 2020).
2. Human Immunodeficiency Viruses in The Developing World
3. Botswana should consider expansion of free antiretroviral therapy to immigrants;J. Int. AIDS Soc,2019
4. Outcomes of the Botswana national HIV/AIDS treatment programme from 2002 to 2010: a longitudinal analysis;Lancet. Glob. Heal,2014
5. Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population;J. Antimicrob. Chemother,2017